^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

ET-02

i
Other names: ET-02, CD19-UCART
Associations
Trials
Company:
EdiGene
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials